QBFM
IPXL

QS Batterymarch Financial Management’s Impax Laboratories, Inc. IPXL Stock Holding History

QS Batterymarch Financial Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5.21M Sell
219,630
-18,800
-8% -$482K 0.14% 227
2014
Q2 		$7.15M Buy
238,430
+35,860
+18% +$967K 0.18% 172
2014
Q1 		$5.35M Buy
202,570
+46,850
+30% +$1.17M 0.11% 274
2013
Q4 		$3.92M Sell
155,720
-1,220
-0.8% -$27.2K 0.08% 364
2013
Q3 		$3.21M Hold
156,940
– – 0.07% 396
2013
Q2 		$3.13M Buy
+156,940
New +$2.79M 0.06% 440

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

QS Batterymarch Financial Management's IPXL Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Impax Laboratories, Inc. (IPXL) stake by 7.9% in Q3 2014, selling an estimated $482K and leaving 219,630 shares worth $5.21M. The position accounts for 0.14% of the portfolio, ranked #227.

QS Batterymarch Financial Management first reported a position in IPXL in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.15M in Q2 2014. 162 funds tracked by Wall St. Rank hold IPXL as of Q3 2014.

  • QS Batterymarch Financial Management held 219,630 shares of Impax Laboratories, Inc. worth $5.21M as of Q3 2014.
  • QS Batterymarch Financial Management sold 18,800 Impax Laboratories, Inc. shares in Q3 2014, an estimated $482K.
  • Impax Laboratories, Inc. made up 0.14% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #227 holding.
  • QS Batterymarch Financial Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's Impax Laboratories, Inc. position peaked at $7.15M in Q2 2014.
  • 162 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.